Alltrna’s CEO Michelle Warner said that the approach allows for basket trials that can group patients with different diseases ...

Shares of biotechnology company Moderna (NASDAQ:MRNA) jumped 11.8% in the morning session after it continued to build on the 3% gain from Friday when it reported fourth-quarter 2024 financial results.

Summary: Scientists have developed a lipid nanoparticle system that enables mRNA to cross the blood-brain barrier, a long-standing challenge in neuroscience. In studies using mice and human brain ...

Researchers at the Icahn School of Medicine at Mount Sinai say they have developed a lipid nanoparticle system capable of delivering messenger RNA (mRNA) to the brain via intravenous injection ...

Blood–brain-barrier-crossing lipid nanoparticles for mRNA delivery to the central nervous system. Nature Materials , 2025; DOI: 10.1038/s41563-024-02114-5 Cite This Page : ...

A lipid nanoparticle system has been developed to deliver mRNA across the blood-brain barrier via intravenous injection, overcoming a significant challenge in treating brain diseases.

Scientists at the Icahn School of Medicine at Mount Sinai have developed a lipid nanoparticle system capable of delivering messenger RNA (mRNA) to the brain via intravenous injection, a challenge ...

New York, NY [February 17, 2025]—Scientists at the Icahn School of Medicine at Mount Sinai have developed a lipid nanoparticle system capable of delivering messenger RNA (mRNA) to the brain via ...

这场逆转充满戏剧性。疫情期间，Moderna以“mRNA第一股”的绝对姿态碾压BioNTech：2021年巅峰时期，市值高达1955亿美元。马斯克更是公开表示mRNA技术 ...

A codon, a sequence of three nucleotides in DNA and RNA that codes for a specific amino ... In this process, known as translation, the genetic information carried in a messenger RNA (mRNA), via the ...